Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis

Biologicals. 2023 Dec 14;85:101737. doi: 10.1016/j.biologicals.2023.101737. Online ahead of print.ABSTRACTCystic Echinococcosis is a cosmopolitan zoonosis closely linked to poverty and ignorance. It affects both cattle and humans, causing significant losses to both human and animal health. To date, there is no effective way to combat this. Our proposal focused on the formulation of poly (lactic-co-glycolic acid (PLGA) and Eudragit-RSPO polymeric nanoparticles, which are suitable to encapsulate an antigen for oral administration in dogs. This antigen, named EgFABP1, belonging to the family of fatty acid-binding proteins, was isolated from the larval form of the parasite Echinococcus granulosus. Several reports point to proteins from this family from parasitic flatworms as candidates for a successful vaccine, considering the restricted lipid metabolism of these organisms. The encapsulation of the antigen yielded an efficiency higher than 50 %, and the nanoparticles showed the expected size range. In addition, antigen integrity was conserved and the formulation was resistant to artificial gastric and intestinal fluid effects.PMID:38101003 | DOI:10.1016/j.biologicals.2023.101737
Source: Biologicals : Journal of the International Association of Biological Standardization - Category: Biotechnology Authors: Source Type: research